MedTrace Logo

Prevention and Decolonization of Multidrug-resistant Bacteria With Probiotics

NCT03967301 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 228

Last updated 2019-08-12

No results posted yet for this study

Summary

This study explores the effect of probiotic administration to decrease colonization by Carbapenem resistant Enterobacteriaceae (CRE) in at-risk populations. Colonized patients will be randomized to receive probiotics or placebo for 14 days and reevaluated for colonization in follow up.

Conditions

  • Probiotics
  • Enterobacteriaceae Infections

Interventions

DIETARY_SUPPLEMENT

Probiotic

Intervention: defined as probiotic consumption

DIETARY_SUPPLEMENT

Placebo

Placebo consumption. The placebo will be provided by the company that produces the probiotic.

Sponsors & Collaborators

  • Hospital Italiano de Buenos Aires

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-31
Primary Completion
2019-12-31
Completion
2019-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03967301 on ClinicalTrials.gov